tiprankstipranks
Merck KGaA (MX:MRK1N)
:MRK1N
Mexico Market
MRK1N
Merck KGaA
RESEARCH TOOLSreports

Merck KGaA (MRK1N) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

MRK1N Analyst Ratings

Moderate Buy
7Ratings
Moderate Buy
3 Buy
4 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Merck
KGaA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MRK1N Stock 12 Month Forecast

Average Price Target

―
Based on 7 Wall Street analysts offering 12 month price targets for Merck KGaA in the last 3 months. The average price target is $2,826.92 with a high forecast of $2,974.67 and a low forecast of $2,541.27. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$2,975Average Price Target$2,827Lowest Price Target$2,541
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Deutsche Bank Analyst forecast on MX:MRK1N
Falko Friedrichs
Deutsche Bank
Deutsche Bank
$2,462.47→$2,777.67
Hold
―
Reiterated
08/11/26
Deutsche Bank Sticks to Its Hold Rating for Merck KGaA (0O14)
Barclays Analyst forecast on MX:MRK1N
Charles Pitman CFA
Barclays
Barclays
$2,757.97
Hold
―
Reiterated
08/07/26
Merck KGaA (0O14) Gets a Hold from Barclays
UBS Analyst forecast on MX:MRK1N
Matthew Weston
UBS
UBS
$2,954.97
Buy
―
Reiterated
08/07/26
Merck KGaA (0O14) Receives a Buy from UBS
DZ BANK AG Analyst forecast on MX:MRK1N
Peter Spengler
DZ BANK AG
DZ BANK AG
―
Buy
―
Reiterated
08/07/26
DZ BANK AG Keeps Their Buy Rating on Merck KGaA (0O14)
Bernstein Analyst forecast on MX:MRK1N
Justin Smith
Bernstein
Bernstein
$2,383.67→$2,974.67
Hold
―
Reiterated
08/07/26
Bernstein Keeps Their Hold Rating on Merck KGaA (0O14)
Jefferies Analyst forecast on MX:MRK1N
James Vane
Jefferies
Jefferies
$2,541.27
Hold
―
Reiterated
08/06/26
Merck KGaA (0O14) Gets a Hold from Jefferies
J.P. Morgan Analyst forecast on MX:MRK1N
Richard Vosser
J.P. Morgan
J.P. Morgan
$2,954.97
Buy
―
Reiterated
06/01/26
J.P. Morgan Reaffirms Their Buy Rating on Merck KGaA (0O14)
Kepler Capital Analyst forecast on MX:MRK1N
David Evans
Kepler Capital
Kepler Capital
$2,994.37
Buy
―
Reiterated
05/01/26
Kepler Capital Reaffirms Their Buy Rating on Merck KGaA (0O14)
Goldman Sachs Analyst forecast on MX:MRK1N
James Quigley
Goldman Sachs
Goldman Sachs
$3,014.07→$2,895.87
Buy
―
Reiterated
04/16/26
Goldman Sachs Remains a Buy on Merck KGaA (0O14)
Morgan Stanley Analyst forecast on MX:MRK1N
Thibault Boutherin
Morgan Stanley
Morgan Stanley
$2,560.97→$2,659.47
Hold
―
Reiterated
12/03/25
Morgan Stanley Remains a Hold on Merck KGaA (0O14)
Stifel Nicolaus Analyst forecast on MX:MRK1N
Dylan Van Haaften
Stifel Nicolaus
Stifel Nicolaus
$2,068.48
Sell
―
Reiterated
11/13/25
Cautious Outlook for Merck KGaA Amidst Unchanged Guidance and Growth Concerns
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Deutsche Bank Analyst forecast on MX:MRK1N
Falko Friedrichs
Deutsche Bank
Deutsche Bank
$2,462.47→$2,777.67
Hold
―
Reiterated
08/11/26
Deutsche Bank Sticks to Its Hold Rating for Merck KGaA (0O14)
Barclays Analyst forecast on MX:MRK1N
Charles Pitman CFA
Barclays
Barclays
$2,757.97
Hold
―
Reiterated
08/07/26
Merck KGaA (0O14) Gets a Hold from Barclays
UBS Analyst forecast on MX:MRK1N
Matthew Weston
UBS
UBS
$2,954.97
Buy
―
Reiterated
08/07/26
Merck KGaA (0O14) Receives a Buy from UBS
DZ BANK AG Analyst forecast on MX:MRK1N
Peter Spengler
DZ BANK AG
DZ BANK AG
―
Buy
―
Reiterated
08/07/26
DZ BANK AG Keeps Their Buy Rating on Merck KGaA (0O14)
Bernstein Analyst forecast on MX:MRK1N
Justin Smith
Bernstein
Bernstein
$2,383.67→$2,974.67
Hold
―
Reiterated
08/07/26
Bernstein Keeps Their Hold Rating on Merck KGaA (0O14)
Jefferies Analyst forecast on MX:MRK1N
James Vane
Jefferies
Jefferies
$2,541.27
Hold
―
Reiterated
08/06/26
Merck KGaA (0O14) Gets a Hold from Jefferies
J.P. Morgan Analyst forecast on MX:MRK1N
Richard Vosser
J.P. Morgan
J.P. Morgan
$2,954.97
Buy
―
Reiterated
06/01/26
J.P. Morgan Reaffirms Their Buy Rating on Merck KGaA (0O14)
Kepler Capital Analyst forecast on MX:MRK1N
David Evans
Kepler Capital
Kepler Capital
$2,994.37
Buy
―
Reiterated
05/01/26
Kepler Capital Reaffirms Their Buy Rating on Merck KGaA (0O14)
Goldman Sachs Analyst forecast on MX:MRK1N
James Quigley
Goldman Sachs
Goldman Sachs
$3,014.07→$2,895.87
Buy
―
Reiterated
04/16/26
Goldman Sachs Remains a Buy on Merck KGaA (0O14)
Morgan Stanley Analyst forecast on MX:MRK1N
Thibault Boutherin
Morgan Stanley
Morgan Stanley
$2,560.97→$2,659.47
Hold
―
Reiterated
12/03/25
Morgan Stanley Remains a Hold on Merck KGaA (0O14)
Stifel Nicolaus Analyst forecast on MX:MRK1N
Dylan Van Haaften
Stifel Nicolaus
Stifel Nicolaus
$2,068.48
Sell
―
Reiterated
11/13/25
Cautious Outlook for Merck KGaA Amidst Unchanged Guidance and Growth Concerns
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Merck KGaA

3 Months
Peter SpenglerDZ BANK AG
Success Rate
26/39 ratings generated profit
67%
Average Return
+4.47%
Copying Peter Spengler's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +4.47% per trade.
1 Year
Peter SpenglerDZ BANK AG
Success Rate
28/39 ratings generated profit
72%
Average Return
+11.81%
Copying Peter Spengler's trades and holding each position for 1 Year would result in 71.79% of your transactions generating a profit, with an average return of +11.81% per trade.
2 Years
Peter SpenglerDZ BANK AG
Success Rate
29/39 ratings generated profit
74%
Average Return
+20.94%
Copying Peter Spengler's trades and holding each position for 2 Years would result in 74.36% of your transactions generating a profit, with an average return of +20.94% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MRK1N Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
1
1
0
0
0
Buy
12
16
12
11
6
Hold
9
13
11
11
10
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
30
23
22
16
In the current month, MRK1N has received 6 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. MRK1N average Analyst price target in the past 3 months is 2,826.92.
Each month's total comprises the sum of three months' worth of ratings.

MRK1N Financial Forecast

MRK1N Earnings Forecast

Next quarter’s earnings estimate for MRK1N is $40.93 with a range of $39.56 to $42.53. The previous quarter’s EPS was $42.73. MRK1N beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year MRK1N has Performed in-line its overall industry.
Next quarter’s earnings estimate for MRK1N is $40.93 with a range of $39.56 to $42.53. The previous quarter’s EPS was $42.73. MRK1N beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year MRK1N has Performed in-line its overall industry.

MRK1N Sales Forecast

Next quarter’s sales forecast for MRK1N is $106.48B with a range of $104.71B to $107.60B. The previous quarter’s sales results were $107.50B. MRK1N beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year MRK1N has Performed in-line its overall industry.
Next quarter’s sales forecast for MRK1N is $106.48B with a range of $104.71B to $107.60B. The previous quarter’s sales results were $107.50B. MRK1N beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year MRK1N has Performed in-line its overall industry.

MRK1N Stock Forecast FAQ

What is MX:MRK1N’s average 12-month price target, according to analysts?
Based on analyst ratings, Merck KGaA’s 12-month average price target is 2,826.92.
    What is MX:MRK1N’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:MRK1N, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Merck KGaA a Buy, Sell or Hold?
        Merck KGaA has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 4 hold ratings and 0 sell ratings.
          What is Merck KGaA’s share price target?
          The average share price target for Merck KGaA is 2,826.92. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $2,974.67 ,and the lowest forecast is $2,541.27. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Merck KGaA?
            Merck KGaA’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
              How can I buy shares of Merck KGaA?
              To buy shares of MX:MRK1N, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.